STEINERT

Clinical trials for STEINERT explained in plain language.

Never miss a new study

Get alerted when new STEINERT trials appear

Sign up with your email to follow new studies for STEINERT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug DYNE-101 aims to ease muscle symptoms in DM1

Disease control Recruiting now

This Phase 3 trial tests whether DYNE-101 can improve muscle function and daily life in 150 adults with myotonic dystrophy type 1 (DM1). Participants receive either the drug or a placebo by IV every few weeks for 48 weeks. The study measures how quickly people can stand from a ch…

Matched conditions: STEINERT

Phase: PHASE3 • Sponsor: Dyne Therapeutics • Aim: Disease control

Last updated Jul 02, 2026 00:00 UTC

STEINERT

Get alerted when new STEINERT trials appear

New drug DYNE-101 aims to ease muscle symptoms in DM1